Tuesday 21st September 2021
|Text too small?|
Kathmandu Holdings Limited is pleased to announce its results for the 12 months ended 31 July 2021 (FY21).
The FY21 Group results were underpinned by strong sales from both Rip Curl and Oboz, and included a full 12 months of Rip Curl (FY20 included 9 months of Rip Curl post-acquisition). Earnings growth further reflected the Group’s focused management of operating expenses, including the benefit of rent abatements, and approx. $15 million annualised restructuring and synergy savings implemented during the onset of the COVID pandemic last financial year.
FY21 key highlights (vs FY20)
• Sales up 15.1% to $922.8 million, including a full 12-month contribution from Rip Curl
• Gross margin up 40 bps to 58.7%
• Underlying EBITDA up 35.9% to $113.3 million (excluding the impact of IFRS 16 and one-off abnormal costs), driven by strong sales performance and focused management of operating expenses
• Statutory NPAT of $63.4 million
• Underlying NPAT up 110% to $66.3 million (excluding the impact of IFRS 16 and one-off abnormal costs)
• Strong balance sheet with $37.0 million net cash, allows the Group to manage any short-term COVID-related challenges while supporting continued growth investment
• Final dividend of 3.0 cents per share (fully franked for Australian shareholders); total FY21 dividend of 5.0 cents per share
Trading update & outlook
Same store sales (including online) for the six full weeks to 12 September 2021 were significantly impacted by ongoing Australasian COVID lockdowns as follows:
• Rip Curl -12.8% overall; +3.6% adjusted for COVID lockdowns
• Kathmandu -19.9% overall; +18.3% adjusted for COVID lockdowns
These results include online sales growth to date of 25.9%, with Kathmandu sales in regions less affected by COVID restrictions performing strongly. Rip Curl and Oboz wholesale order books are now significantly above pre-COVID levels.
In addition to ongoing Australasian lockdowns, COVID restrictions are also impacting the Group’s supply chain. Suppliers have reduced factory capacity due to enforced closures, and freight congestion is leading to delivery delays and increased freight costs.
As a result, first half FY22 profit is expected to be below first half FY21.
Please see the links below for details
No comments yet
Deferral of FDA consideration of enforcement discretion
MHJ - Response to ASX Query
CDI 2022 Interim Results
August 10th Morning Report
TWL - Resignation of Chief Operating Officer
NZA - Funding arrangements following Board changes
August 9th Morning Report
August 8th Morning Report
BIF - Potential material valuation increase for the fund
Nominations open for Fonterra Board of Directors' Election